VEGFA and age-related macular degeneration: Small synthetic novel RNA oligonucleotides (nkRNA and PnkRNA) targeting mouse VEGF were transfected into a mouse endothelial cell line (UVfemale2) by commercial HiPerFect (a unique mixture of cations and neutral lipids; Qiagen, Valencia, CA), and they inhibited AMD-associated angiogenesis via the Toll-like receptor 3-independent pathway.133